Sabra Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Sabra Healthcare REIT
SBRA Stock  USD 17.78  0.16  0.91%   
Sabra Healthcare financial statements provide useful quarterly and yearly information to potential Sabra Healthcare REIT investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Sabra Healthcare financial statements helps investors assess Sabra Healthcare's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Sabra Healthcare's valuation are summarized below:
Gross Profit
476.1 M
Profit Margin
0.1803
Market Capitalization
4.2 B
Enterprise Value Revenue
9.2428
Revenue
702.6 M
We have found one hundred twenty available fundamental trend indicators for Sabra Healthcare REIT, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of Sabra Healthcare REIT current market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. The current year's Market Cap is expected to grow to about 4.2 B, whereas Enterprise Value is forecasted to decline to about 3.3 B.

Sabra Healthcare Total Revenue

428.88 Million

Check Sabra Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sabra Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 121.5 M, Interest Expense of 86.1 M or Selling General Administrative of 31.2 M, as well as many indicators such as Price To Sales Ratio of 9.78, Dividend Yield of 0.0646 or PTB Ratio of 1.53. Sabra financial statements analysis is a perfect complement when working with Sabra Healthcare Valuation or Volatility modules.
  
Check out the analysis of Sabra Healthcare Correlation against competitors.

Sabra Healthcare Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4.3 B5.3 B3.9 B
Slightly volatile
Short and Long Term Debt Total2.2 B1.8 B2 B
Slightly volatile
Total Current Liabilities1.9 B1.8 B302.9 M
Slightly volatile
Total Stockholder Equity2.2 B2.7 B2 B
Slightly volatile
Other Liabilities47.8 M40.4 M49.8 M
Pretty Stable
Property Plant And Equipment Net3.3 B5.3 B1.9 B
Slightly volatile
Net Debt1.9 B1.7 B1.7 B
Slightly volatile
Accounts Payable76.6 M84.9 M71.1 M
Slightly volatile
Cash85.3 M60.5 M78 M
Very volatile
Non Current Assets Total3.9 B4.7 B3.5 B
Slightly volatile
Other Assets368 M387.3 M802.7 M
Slightly volatile
Long Term Debt2.4 B2.3 B1 B
Slightly volatile
Cash And Short Term Investments85.3 M60.5 M78 M
Very volatile
Common Stock Total Equity2.8 M2.7 M1.5 M
Slightly volatile
Common Stock Shares Outstanding139.7 M236 M127.8 M
Slightly volatile
Short Term Investments20.7 M21.8 M66.1 M
Slightly volatile
Liabilities And Stockholders Equity4.3 B5.3 B3.9 B
Slightly volatile
Non Current Liabilities Total759.5 M799.5 M1.6 B
Slightly volatile
Other Stockholder Equity2.9 B2.7 B2.6 B
Slightly volatile
Total Liabilities2.1 B2.6 B1.9 B
Slightly volatile
Property Plant And Equipment Gross627.4 M757.1 M651.6 M
Slightly volatile
Total Current Assets376.1 M192.2 M344.1 M
Slightly volatile
Common Stock1.5 M2.4 M1.4 M
Slightly volatile
Intangible Assets26.1 M27.5 M47.5 M
Pretty Stable
Net Tangible Assets2.4 B3.5 B2.1 B
Slightly volatile
Net Receivables241.2 M131.8 M194.7 M
Slightly volatile
Long Term Debt Total2.8 B2.7 B1.1 B
Slightly volatile
Capital Surpluse2.9 B5.2 B2.6 B
Slightly volatile
Short Term Debt979.4 M1.8 B796.2 M
Slightly volatile
Long Term Investments169.8 M182.9 M120.8 M
Slightly volatile
Short and Long Term Debt101.2 M106.6 M795.7 M
Slightly volatile
Capital Lease Obligations46.1 M26.8 M74.6 M
Slightly volatile
Net Invested Capital4.7 B5.2 B6.2 B
Slightly volatile
Non Current Liabilities Other49.6 M29.3 M74.9 M
Slightly volatile
Net Working Capital255.7 M355.1 M490.7 M
Slightly volatile
Capital Stock2.4 M2.4 M2 M
Slightly volatile

Sabra Healthcare Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization121.5 M169.6 M111.2 M
Slightly volatile
Selling General Administrative31.2 M50.1 M28.5 M
Slightly volatile
Total Revenue428.9 M703.2 M392.3 M
Slightly volatile
Gross Profit338.8 M476.1 M309.9 M
Slightly volatile
Other Operating Expenses738.4 M703.2 M262.1 M
Slightly volatile
Operating Income171.2 M257 M156.6 M
Slightly volatile
EBITDA284 M412.6 M259.8 M
Slightly volatile
Total Operating Expenses500 M476.1 M170.7 M
Slightly volatile
Cost Of Revenue238.4 M227.1 M99.2 M
Slightly volatile
Net Income From Continuing Ops80.9 M126.7 M89.7 M
Pretty Stable
Preferred Stock And Other Adjustments10.8 M11.2 M9.6 M
Slightly volatile
Tax Provision1.7 M1 M1.3 M
Slightly volatile
Reconciled Depreciation191.1 M169.6 M148.2 M
Slightly volatile
Interest Income6.7 M7.8 M6.1 M
Slightly volatile

Sabra Healthcare Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation8.1 M9 M7.4 M
Slightly volatile
Depreciation121.6 M169.6 M111.2 M
Slightly volatile
Total Cash From Operating Activities224.1 M310.5 M205 M
Slightly volatile
End Period Cash Flow88.6 M66.3 M81.1 M
Very volatile
Begin Period Cash Flow44.4 M46.7 M83.1 M
Very volatile
Dividends Paid209.6 M280.1 M181.8 M
Slightly volatile
Issuance Of Capital Stock73.6 M77.5 M251.7 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio9.785.75088.9501
Slightly volatile
Dividend Yield0.06460.06930.0801
Pretty Stable
PTB Ratio1.531.47531.4018
Slightly volatile
Days Sales Outstanding64.9768.3848180
Pretty Stable
Book Value Per Share12.2511.740115.1217
Pretty Stable
Operating Cash Flow Per Share1.281.32991.5815
Very volatile
Stock Based Compensation To Revenue0.01210.01280.03
Slightly volatile
Capex To Depreciation0.210.222.2365
Slightly volatile
PB Ratio1.531.47531.4018
Slightly volatile
EV To Sales7.768.171715.076
Slightly volatile
Inventory Turnover0.430.451.4377
Slightly volatile
Days Of Inventory On Hand873831378
Slightly volatile
Payables Turnover4.844.611.3437
Slightly volatile
Sales General And Administrative To Revenue0.110.07120.0991
Slightly volatile
Average Inventory64.6 M86.3 M72.5 M
Slightly volatile
Capex To Revenue0.06450.06790.6631
Slightly volatile
Cash Per Share0.250.2591.0061
Pretty Stable
POCF Ratio16.8413.023115.4082
Slightly volatile
Interest Coverage2.152.261.9471
Very volatile
Capex To Operating Cash Flow0.10.111.5947
Slightly volatile
Days Payables Outstanding77.7881.871.7 K
Slightly volatile
EV To Operating Cash Flow29.8818.505127.3323
Slightly volatile
Intangibles To Total Assets0.00490.00520.0117
Slightly volatile
Net Debt To EBITDA3.924.125910.7283
Slightly volatile
Current Ratio0.10.1094.4544
Slightly volatile
Tangible Book Value Per Share12.0211.622414.8364
Pretty Stable
Receivables Turnover5.65.33743.9195
Pretty Stable
Graham Number12.8211.972714.3242
Pretty Stable
Shareholders Equity Per Share12.2511.740115.1175
Pretty Stable
Debt To Equity1.240.64311.1331
Slightly volatile
Capex Per Share0.170.182.1826
Slightly volatile
Revenue Per Share2.463.01173.0415
Very volatile
Interest Debt Per Share7.648.043516.2704
Slightly volatile
Debt To Assets0.540.33240.4965
Slightly volatile
Enterprise Value Over EBITDA13.2313.927425.43
Slightly volatile
Short Term Coverage Ratios0.170.176241.1518
Slightly volatile
Operating Cycle64.9768.3848282
Pretty Stable
Price Book Value Ratio1.531.47531.4018
Slightly volatile
Days Of Payables Outstanding77.7881.871.7 K
Slightly volatile
Price To Operating Cash Flows Ratio16.8413.023115.4082
Slightly volatile
Operating Profit Margin0.470.390.4324
Pretty Stable
Company Equity Multiplier2.431.93472.2242
Slightly volatile
Long Term Debt To Capitalization0.570.520.5216
Slightly volatile
Total Debt To Capitalization0.560.39140.5153
Slightly volatile
Return On Capital Employed0.04940.0430.0455
Pretty Stable
Debt Equity Ratio1.240.64311.1331
Slightly volatile
Ebit Per Revenue0.470.390.4324
Pretty Stable
Quick Ratio0.10.1094.1566
Slightly volatile
Dividend Paid And Capex Coverage Ratio0.781.10850.9181
Slightly volatile
Net Income Per E B T0.940.99213.2291
Slightly volatile
Cash Ratio0.03260.03430.8905
Slightly volatile
Operating Cash Flow Sales Ratio0.590.44160.539
Pretty Stable
Days Of Inventory Outstanding873831378
Slightly volatile
Days Of Sales Outstanding64.9768.3848180
Pretty Stable
Cash Flow Coverage Ratios0.180.17620.1145
Slightly volatile
Price To Book Ratio1.531.47531.4018
Slightly volatile
Fixed Asset Turnover0.110.1264.55
Very volatile
Capital Expenditure Coverage Ratio10.029.544.0481
Slightly volatile
Price Cash Flow Ratio16.8413.023115.4082
Slightly volatile
Enterprise Value Multiple13.2313.927425.43
Slightly volatile
Debt Ratio0.540.33240.4965
Slightly volatile
Cash Flow To Debt Ratio0.180.17620.1145
Slightly volatile
Price Sales Ratio9.785.75088.9501
Slightly volatile
Asset Turnover0.07830.13260.0967
Slightly volatile
Gross Profit Margin0.90.67710.8649
Slightly volatile
Price Fair Value1.531.47531.4018
Slightly volatile

Sabra Healthcare Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap4.2 B4 B2.3 B
Slightly volatile
Enterprise Value3.3 B5.7 B3.8 B
Slightly volatile

Sabra Fundamental Market Drivers

Forward Price Earnings8.7108
Cash And Short Term Investments60.5 M

Sabra Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Sabra Healthcare Financial Statements

Sabra Healthcare stakeholders use historical fundamental indicators, such as Sabra Healthcare's revenue or net income, to determine how well the company is positioned to perform in the future. Although Sabra Healthcare investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sabra Healthcare's assets and liabilities are reflected in the revenues and expenses on Sabra Healthcare's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sabra Healthcare REIT. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-66.4 M-69.7 M
Total Revenue703.2 M428.9 M
Cost Of Revenue227.1 M238.4 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.07  0.11 
Capex To Revenue 0.07  0.06 
Revenue Per Share 3.01  2.46 
Ebit Per Revenue 0.39  0.47 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce
When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:
How To Invest In Sabra
Details
Is Sabra Stock a good investment?
Details
What is Sabra Healthcare's Net Worth?
Details
Largest Diversified REITs Companies
View
Largest Equity Real Estate Investment Trusts (REITs) Companies
View
Check out the analysis of Sabra Healthcare Correlation against competitors.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.827
Dividend Share
1.2
Earnings Share
0.54
Revenue Per Share
3.009
Quarterly Revenue Growth
0.125
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY